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A B S T R A C T
As the prostate cancer (PCa) progresses, sarcosine levels increase both in tumor cells and urine samples, suggesting that his metabolite measurements can help in 
the creation of non-invasive diagnostic methods for this disease. In this work, a biosensor device was developed for the quantiﬁcation of sarcosine via electrochemical 
detection of H2O2 (at 0.6 V) generated from the catalyzed oxidation of sarcosine. The detection was carried out after the modiﬁcation of carbon screen printed 
electrodes (SPEs) by immobilization of sarcosine oxidase (SOX) on the electrode surface. The strategies used herein included the activation of the carbon ﬁlms by an 
electrochemical step and the formation of an NHS/EDAC layer to bond the enzyme to the electrode, the use of metallic or semiconductor nanoparticles layer 
previously or during the enzyme immobilization. In order to improve the sensor stability and selectivity a polymeric layer with extra enzyme content was further 
added. The proposed methodology for the detection of sarcosine allowed obtaining a limit of detection (LOD) of 16 nM, using a linear concentration range 
between 10 and 100 nM. The biosensor was successfully applied to the analysis of sarcosine in urine samples.
. Introduction
Prostate cancer (PCa) is the most common form of cancer in men in Europe with a 61.4% incidence among all cancer cases 
nd a 12.1% mortality [1] and, therefore, its early detection is fundamen-tal for increasing the survival rate. Currently, 
iagnosis and management of patients with PCa is only based on the
Fig. 1. Calibration curves obtained at different potential values using sensor # 9.
Fig. 2. Calibration curves obtained for different concentration the immobilization
of sarcosine oxidase.determination of the biomarker prostate speciﬁc antigen (PSA). In
biological samples (urine and blood plasma) sarcosine concentra-
tion can range between 1 and 20 mM [2]. However, the method
used for PCa detection has poor sensitivity and speciﬁcity, leading
to false–negative and false–positive test results and therefore,
many patients are sent to unnecessary biopsy procedures [3].
Therefore, there is a need to seek for new biomarkers and more
effective screening.
In 2009, a pilot study created a non-invasive method to identify
the presence and aggressiveness of PCa disease, which was based
on sarcosine, a metabolite of the amino acid glycine that can be
detected in urine [4]. The analytical methods available for direct
determination of sarcosine in urine or serum often include
chromatography [5–9] and differential mobility analysis [10] with
mass spectroscopy. The major disadvantages of these techniques
are high instrumentation costs, and complex sample preparation
and skilled operator requirements, which is not suitable for routine
analysis.
The direct determination of sarcosine may be difﬁcult, but its
indirect quantiﬁcation can be achieved by the reaction between
sarcosine and sarcosine oxidase (SOX), which catalyses the
oxidative demethylation of sarcosine to glycine, formaldehyde,
and hydrogen peroxide. The methods commonly used for the
indirect determination of sarcosine are colorimetry [11,12],
ﬂuorimetry [13] and electrochemical sensors with immobilization
of the enzyme on the electrode surface [14–18]. The enzyme
immobilization is a promising choice, due to the intrinsic
advantages associated with their high catalytic activity and
enzyme speciﬁcity for their substrates. The electrode surfaces
usually can be mass produced, stored and used as required and in
some cases re-used decreasing the cost of the detection process.
In this work, we describe the construction of a novel sarcosine
biosensor based on the covalent immobilization of SOX, using
N-ethyl-N-(3-dimethylaminopropyl) carbodiimide (EDC) and
N-hydroxysuccinimide (NHS), on the surface of the screen-printed
carbon electrode. The selectivity of the electrochemical biosensor
was improved by covering the electrode surface with Naﬁon1.
Naﬁon is used due to its ﬁlm hydrophobicity and enzyme-favored
environment as well as to enhance selectivity of the sensor by
electrostatic repulsion of unwanted species [19,20].
The quantiﬁcation of sarcosine is achieved herein via electro-
chemical detection of H2O2 (Eq. (2)) resulting from the catalyzed
oxidation of sarcosine (Eqs. (1) and (2)), i.e., sarcosine oxidase
converts sarcosine to glycine, formaldehyde and H2O2.
Sarcosine þ H2O þ O2 !SOX Formaldehyde þ Glycine H2O2 (1)
H2O2 !0:6VO2 þ 2Hþ þ 2e (2)
For this purpose, this work presents a systematic investigation
study of several experimental parameters. Calibration slopes,
dynamic linear range, limit of detection, and selectivity were
investigated to evaluate the performance of the sarcosine
biosensor for PCa fast and non-invasive screening.
2. Experimental procedure
2.1. Reagents and solutions
Sarcosine oxidase from Bacillus sp (lyophilized powder,
25–50 units/mg), N-ethyl-N-(3-dimethylaminopropyl) carbodii-
mide hydrochloride (EDAC), Naﬁon1 117 solution, glutaraldehyde
(50%), sodium sulfate, potassium phosphate, ammonium chloride,
urea and creatinine were purchased from Sigma–Aldrich.
N-Hydroxysuccinimide (NHS) was obtained from Fluka; sodiumchloride from Panreac; and calcium chloride dihydrate and
potassium chloride were obtained from Merck. All the chemicals
were of analytical grade and used without further puriﬁcation.
Phosphate buffer solutions (PBS) at pH 7.2 were used in this
work and were prepared with 0.1 M NaHPO4 and 0.1 M Na2PO4.
Stock solutions of sarcosine (C = 1 103M) were prepared in PBS
(pH 7.2) and less concentrated standards were prepared by suitable
dilution in the buffer solution. The urine solution used had the
following composition: calcium chloride dihydrate (1.103 g L1),
sodium chloride (2.295 g L1), sodium sulfate (2.25 g L1), potassi-
um phosphate (1.40 g L1), potassium chloride (1.60 g L1), ammo-
nium chloride (1.00 g L1), urea (25 g L1) and creatinine
(1.10 g L1) [21]. Ultra-pure water (conductivity > 18 MV cm at
25 C) was used throughout.
2.2. Apparatus
The electrochemical measurements were carried out using a
potentiostat/galvanostat Autolab Eco Chemie PSTAT10 interfaced
to a computer with GPES 4.9 software. Carbon screen-printed
electrodes (SPEs, 4 mm diameter, DRP-C110) were used as working
electrodes and were purchased from DropSens (Spain). SPEs were
Fig. 3. Analytical response of the chips fabricated in this work for the increasing
concentrations values of sarcosine.connected to the Autolab by means of a suitable DropSens adaptor
box.
Atomic force microscopy (AFM) images were recorded using a
Molecular Imaging, PicoLe atomic force microscope. The surface
topography was measured using a silicon cantilever/tip (App Nano,
model ACT) with a resonance frequency between 200 and 400 kHz.
2.3. Procedures
2.3.1. Immobilization of sarcosine oxidase
Aiming to choose the best electrode material and the best SOX
immobilization procedure a systematic study was carried out using
gold and carbon SPE. The results obtained with gold electrode
proved not to be satisfactory (the voltammograms were not stableFig. 4. Scheme of the immobilization proceswith signal interferences and therefore higher LOD and reduced
linearity was obtained) and this material was discarded in the early
stages of this work.
SPE electrodes with carbon ﬁlms and carbon ﬁlms containing
nanotubes were further tested using different conditions of SOX
immobilization with the purpose of increasing enzyme stability
and biosensor sensitivity. A summary of the different biosensor
conﬁgurations studied in this work is presented in Supplementary
information, Table S1.
In this paper we describe different immobilization procedures
of SOX on the surface of carbon or carbon nanotubes SPE's. The
cleaning and oxidation of the carbon electrodes surface was
achieved by 30 potential cycles between the potential range from
0.2 to +1.0 V (scan rate: 100 mV s1) in 0.5 M sulfuric acid to
ensure that the carboxylic acid groups remain on the surface. The
electrodes were then thoroughly rinsed with ultra-pure water and
dried under N2.
For the sensors # 1, 2, 8, 9 and 10 (Supplementary information,
Table S1), COOH groups were activated by covering the electrode
surface with 5 mL of a NHS/EDAC solution (10 mM in PBS) for 6 h at
room temperature. The reaction of NHS and EDAC at the electrode
surface lead to the formation of stable ester surface groups, giving
rise to carbon activated surface. The excess of EDAC and NHS was
removed by washing the chip with PBS [16]. The COOH groups
present in the electrode surfaces of the sensors # 3–7 were not
activated.
In the following step, gold (Au) or zinc oxide (ZnO) nano-
particles were used to modify the electrode surfaces by complete
evaporation of the aqueous nanoparticles solutions (5 mL): sensors
5 and 6 were modiﬁed by gold nanoparticles (0.5 nm), synthe-
sized by following the protocol of Chirea et al. [22], and sensor #
10 was modiﬁed by ZnO (200 nm) nanoparticles, synthesized by
using the protocol of Jezequel et al. [23]. The electrode surface was
washed with PBS to remove the excess of nanoparticles and dried
under N2.
The last step of the modiﬁcation process consists in the
immobilization the enzyme sarcosine oxidase (SOX) on the
electrode surface by using different immobilization procedures.s of SOX on SPE surface for sensor # 9.
Fig. 5. EIS study over the subsequent modiﬁcation steps of the carbon-SPE in
5.0 mM [Fe(CN)6]3 and 5.0 mM [Fe(CN)6]4 in PBS buffer.The different electrode surface immobilization processes of SOX
are described in Table S1. Electrode surface of sensors # 1, 2 and
9 were modiﬁed by depositing 5 mL of SOX solution (1 mg mL1 in
PBS) on the surface of the carbon electrode at 4 C during 20 h for
sensors # 1 and 2 and 6 h for sensor # 9; electrode surface of
sensors # 3–6 were modiﬁed by dissolving 1 mg SOX in a mixture
of 20 mL PBS and 20 mL 10% glutaraldehyde. A volume of 5 mL of this
solution was applied onto the surface at 4 C during 20 h [14];
ﬁnally, electrode surfaces from sensors # 7–10 were modiﬁed by
dissolving 1 mg of SOX in a mixture of 20 mL of PBS and 20 mL of
Naﬁon1 2.5% [18]. A volume of 5 mL of this solution was applied
onto the surface of the electrodes at 4 C during 20 h. All electrodes
were washed with PBS and dried under N2.
2.3.2. Electrochemical measurement and optimization of sarcosine
biosensor
The sensitivity of sarcosine biosensor was tested by measuring
current as function of the applied potential for different solutions
with increasing amounts of sarcosine.
Initially 5 mL sarcosine solution (5 106–3  101mM in 0.1 M,
pH 7.2) was placed at the surface of the sensors and a potential scan
was applied using a potential range of 1.5 to 0.9 V.
EIS assays were made with redox couple [Fe(CN)6]3/4 at a
potential of +0.12 V, using a sinusoidal potential perturbation with
an amplitude of 0.01 V and the number of frequencies equal to 50,
logarithmically distributed over a frequency range of 0.1–100 kHz.Table 1
Fitting parameters extracted from electrochemical impedance data using the Randles e
Oxidation carbon COOH activation
R (V) 269.5 259
C (mF) 6.32 4.91
Rct (V) 40.5 128.5
W (V s1/2) 4.16  1003 2.50  10032.3.3. Determination of sarcosine in synthetic urine
Synthetic urine solution with different concentrations of
sarcosine was used for the evaluation sensor # 9 response. This
solution was prepared by adding a known amount of sarcosine
(15–65 nM) on to the synthetic urine solution.
3. Results and discussions
3.1. Optimization of the experimental condition for sarcosine detection
Experiments were carried out using a 0.1 M PBS pH 7.2 as
electrolyte solution since it is close to the physiological conditions.
In addition, this pH value is within the pH range where sarcosine
oxidase has maximum stability (from 7 to 10 in 0.1 M PBS) [24].
The sensitivity of sarcosine biosensor was tested by measuring
the current as function of the applied potential (cyclic voltammo-
grams) in the potential range from 1.5 to 0.9 V for the different
solutions (5 mL) with increasing concentration of sarcosine (data
not shown). The tested sarcosine concentration range was from
0.5 to 100 mM. The cyclic voltammogram obtained in the absence
of sarcosine was used as the baseline in this work.
The optimization of the potential value that corresponds to the
maximum current obtained due to H2O2 oxidation produced by the
catalytic decomposition of sarcosine by SOX (Eqs. (1) and (2)) is
fundamental to achieve the lowest detection limit and to minimize
the interference from other species present in solution. As an
example, the current due to the oxidation of H2O2 for the different
concentration of sarcosine was measured for 3 different potentials
(0.1, 0.4 and 0.6 V) using sensor # 9, as shown Fig. 1. The current
values (n = 3) were corrected to eliminate the baseline contribu-
tion. After analysis of the Fig. 1 it is observed that, although, the
steady state current response increased with increasing concen-
tration of sarcosine for the three potentials studied, the potential of
0.6 V was selected because it clearly presented the highest current
values, increasing the sensitivity of the sarcosine determination.
The optimization of the effect of sarcosine oxidase concentra-
tion on the performance of the sarcosine biosensor was also
performed and the results obtained are represented in Fig. 2.
Increasing the concentration of sarcosine oxidase as the inconve-
nience of increasing the cost of the analysis furthermore, from the
analysis of data the maximum current obtained is around 20% less
than the current obtained using 1 mg mL1 of sarcosine oxidase. In
addition, the current for the lowest sarcosine concentration tested
in this evaluation (1 mM) signiﬁcantly decreases, reducing the
linear range of the biosensor response. This may be due to steric
effects impairing the interaction between sarcosine and sarcosine
oxidase molecules.
Reducing the concentration of sarcosine oxidase to a 0.5 mg
mL1 level does not change the maximum current obtained
however the current for the lowest sarcosine concentration tested
in this evaluation (1 mM) is lower than that obtained at 1 mg mL1
sarcosine oxidase, reducing the linear range of the biosensor
response. For those reasons we conﬁrm that the use of 1 mg mL1
provides better performance of the biosensor reported in this work
(Fig. 3).quivalent circuit.
Immobilization of enzyme Entrapment the enzyme
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Fig. 6. AFM images in 2D (left) and 3D (right) for the different modiﬁcation of surface SPE electrode.3.2. Optimization of sensor construction method
For the selection of the best sensor fabricated in this work, all
sensors were used to measure solutions with different sarcosine
concentrations and the results are presented in Fig. 3. As can beFig. 7. Raman spectroscopy and Fourier transformed infrared spectroscopy (FTIR)
analysis.seen in this ﬁgure, sensor # 9 was selected as the best sensor
because it presented the highest current values for the same
concentration value.
The overall process for the immobilization of SOX on the SPE
surface established for sensor # 9 is described in Fig. 4. The ﬁrst
step shows the oxidation of the carbon surface to ensure that the
carboxylic acid groups are available at the electrode surface. These
groups were then activated via addition of an EDAC/NHS solution
and forming ester surface groups, giving rise to a carbon activated
surface. In the following step, the enzyme covalent immobilization
was achieved by addition of a SOX solution allowing the amine
group to react with the ester forming an amide bond, resulting in a
covalent immobilization of the enzyme. Finally, a mixture of Naﬁon
and SOX was added in order to entrap the enzyme under a
favorable environment where the electrochemical features were
simultaneously enhanced.
EIS studies were used to follow the carbon-SPE modiﬁcation
after each chemical change. These can be measured by monitoring
the changes in the electron transfer properties of well-known
redox systems, such as [Fe(CN)6]4/[Fe(CN)6]3 (Fig. 5).
Results in Fig. 5 clearly show an increase in the resistance of
charge transfer when the several sensor layers are built. This
reﬂects the introduction of negative charges at the electrode
surface and the increase in the difﬁculties in the transport of [Fe
(CN)6]4/[Fe(CN)6]3 ions toward the electrode surface after the
entrapment of the enzyme (this corresponds to the highest
increase in charge transfer resistance). Data was ﬁtted to the
Randles equivalent circuit in order to extract the numerical values
of the charge transfer resistance and those values are displayed in
Table 1.
Fig. 8. Calibration curve obtained for sarcosine in the concentration range used.
Inset: Linear calibration plot obtained for sarcosine.3.3. Surface characterization morphological by AFM, Raman and FTIR
AFM was used to investigate the morphology of the electrode
surface before and along the enzyme immobilization process; the
images collected are shown in Fig. 6. The top image shows the
typical morphology of a clean carbon electrode surface, showing
the surface roughness typical of the carbon ink ﬁlms used in the
fabrication of SPEs carbon electrodes.
The root mean square (RMS) surface roughness initially
obtained after the oxidation of the carbon at the electrode surface
is 27.4 nm (Fig. 6, top) and decreases to 22.1 nm after the activation
step of the carboxylic acid groups (Fig. 6, middle). After the last
step of the modiﬁcation procedure, the immobilization and
entrapment of enzyme, the RMS value decreases to 12.9 nm
(Fig. 6, bottom), indicating that the materials deposit during the
successive steps contribute to the decrease the electrodes surface
roughness. This can be used as indicative of the success of the
immobilization steps.
All chemical modiﬁcations made to the carbon electrode were
followed by Raman spectroscopy and Fourier transformed infrared
spectroscopy (FTIR) analysis. This study was applied to the different
stages of the SPE preparation shown in Fig. 4: Blank, EDAC/NHS, SOX
and Naﬁon/SOX. As may be seen in the Raman spectra (Fig. 7A), the
relative intensities of the typical G and D peaks of the carbon matrix
have changed signiﬁcantly in all stages of chemical modiﬁcation.
This relative intensity variations account, among others, changes in
the ratio of sp2 and sp3 carbon hybridization in each staged of the SPE
development, therefore conﬁrming the occurrence of chemical
change at the workingelectrode. Regarding the FTIR spectra (Fig. 7B),
and as expected, only the presence of Naﬁon was perceptible above
the carbon matrix. The corresponding spectra displayed two strong
absorption peaks, at 1153 and 1219 cm1, typically assigned to the
symmetric and asymmetric stretching of CF2 groups, respectively
[25].Table 2
Determination of sarcosine in urine samples.
Sample Sarcosine
(mM)
Found
(mM)
1 1.50  105 1.82  105 3.56
2 6.50  105 6.75 105 4.05
3 9.00  105 8.50  105 3.243.4. Evaluation of sarcosine biosensor
After the modiﬁcation of the electrode surface, the biosensor
fabricated was used in the quantiﬁcation of sarcosine. The
hydrogen peroxide generated from the oxidation of sarcosine at
the electrode surface (E = 0.6 V) was measured as a function of the
sarcosine concentration. The calibration curve obtained is shown
in Fig. 8 for the concentration range between 5.0 nM and 0.3 mM.
As can be seen in the ﬁgure, a saturation of the analytical signal is
observed for concentration values greater than 0.1 mM which as
characteristic of the enzymatic systems. Furthermore, a linear
relationship was obtained for sarcosine concentrations ranging
from 10 nM to 0.1 mM, with a correlation coefﬁcient 0.9966, as
shown in the inset of Fig. 8.
The limit of detection (LOD) was calculated according to the
Analytical Methods Committee recommendations [26,27] and
using a signal-to-noise ratio of 3. An LOD of 16 nM was obtained for
the proposed quantiﬁcation methodology. The LOD obtained in
this work is about one order of magnitude lower than the LOD
found in the literature for the electrochemical detection of
creatinine [15–17]. Comparing to the devices described in the
literature for the detection of sarcosine a much higher value is
published for the electrochemical device (28 mM) [18] and a
similar value is found for the optical sensor (5 nM) [12]. However it
is important to mention that the optical sensor operates at 37 C,
requires sample pre-treatment and cannot be reused.
3.5. Interference study and selectivity and electrode stability
Species that coexist with sarcosine in the biological ﬂuids, such
as creatinine and/or urea [17], can interfere in the detection of this
molecule [7]. The interference study was carried out by comparing
the LODs obtained in absence and in the presence of creatinine
1.10 g L1 and urea 25 g L1 [21] and the results obtained are
resumed in Supplementary information Table S2. The LODs were
estimated from calibration curves obtained in the same linear
region. The results obtained indicate that the LODs obtained for
sarcosine in the presence of the interferents tested are greater than
the obtained for sarcosine in the absence of the interferent which
can be explained by the increase of the standard deviation of the
baseline (blank solution + interferent  g L1).
Storage of the biosensor is an important parameter, because the
immobilized enzyme on the electrode surface can lose activity. In
this work, the biosensor was stored at 4 C and the biosensor could
be reused several times (10) with stable results within a period of
60 days. After this period of time, the biosensor performance
decreases signiﬁcantly. When comparing the results obtained for
different biosensors prepared using the same immobilization
procedure an average relative standard deviation of 2% is found.
3.6. Application
Sensor # 9 was applied in the determination of sarcosine in
artiﬁcial systems with the determination of the molecule in urine
samples. Blank samples of synthetized urine were spiked with
sarcosine in order to obtain concentrations values ranging fromRecovery
(%)
Relative error
(%)
  103 120.9  23.7 21.0
 106 103.8  6.23 3.8
 106 94.4  3.60 5.6
15 to 65 nM. The results obtained for the three concentration
values are summarized in Table 2.
For samples 2 and 3, the recoveries ratios obtained were 103.8%
and 94.4%, respectively, corresponding to relative standard
deviation errors inferior to 6%. For sample 1, a relative error of
21% was obtained, which can be explained by the fact that the
concentration of sarcosine in the urine sample is very close to the
LOD of the methodology, increasing the error in the determination
of sarcosine.
4. Conclusions
In this study, a simple and low cost electrochemical enzymatic
biosensor for the determination of sarcosine in urine, based on the
covalent immobilization of SOX, using EDC and NHS, on the surface
of the screen-printed carbon electrode has been developed. The
biosensor presented high analytical performance features, such as
large concentration linear range (10–100 nM), low detection limit
(16 nM) and large storage stability (60 days). The biosensor was
successfully applied to the analysis of sarcosine in synthetic urine
samples.
The proposed detection methodology can be particularly
suitable for screening assays carried out in analytical laboratories.
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